日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SREBF1-mediated SND1 transcriptional activation promotes prostate cancer progression via MTDH interaction through the SESN2/AMPK/mTOR axis.

SREBF1 介导的 SND1 转录激活通过 SESN2/AMPK/mTOR 轴与 MTDH 相互作用促进前列腺癌进展

Tang Yijie, Ying Yufan, Ma Xueyou, Yi Jiahe, Liu Zixiang, Wu Yuqing, Lin Shen, Shu Xuan, Qi Zhixiang, Luo Jindan, Zheng Xiangyi, Li Jiangfeng, Xie Liping, Liu Ben

Research hotspots of prostate cancer at the international conferences on urology in 2022

2022年国际泌尿外科会议上前列腺癌的研究热点

Yi, Jiahe; Li, Jiangfeng; Xie, Liping

SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration and proliferation in bladder cancer

SMAD3 和 FTO 参与 miR-5581-3p 介导的膀胱癌细胞迁移和增殖抑制。

Sun, Jiazhu; Ma, Xueyou; Ying, Yufan; Wang, Weiyu; Shen, Haixiang; Wang, Song; Xie, Haiyun; Yi, Jiahe; Zhan, Weitao; Li, Jiangfeng; Liu, Ben

circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis.

circKDM4C 通过 miR-200bc-3p/ZEB1 轴增强膀胱癌的侵袭和转移

Ma Xueyou, Ying Yufan, Sun Jiazhu, Xie Haiyun, Li Jiangfeng, He Liujia, Wang Weiyu, Chen Shiming, Shen Haixiang, Yi Jiahe, Luo Jindan, Wang Xiao, Zheng Xiangyi, Liu Ben, Xie Liping

Clinicopathological characteristics of androgen receptor splicing variant 7 (AR-V7) expression in patients with castration resistant prostate cancer: A systematic review and meta-analysis

去势抵抗性前列腺癌患者雄激素受体剪接变体7(AR-V7)表达的临床病理特征:系统评价和荟萃分析

Li, Qinchen; Wang, Zhize; Yi, Jiahe; Shen, Haixiang; Yang, Zitong; Yan, Libin; Xie, Liping